Generic Name: Naratriptan
Therapeutic Class: 5-HT1 Receptor Agonist (Triptan) / Anti-migraine
Indications
Naratriptan is a selective serotonin receptor agonist used for the acute treatment of migraine:
- Acute Migraine: Treatment of acute migraine attacks with or without aura in adults.
- Recurrent Migraine: It is particularly noted for its longer half-life, making it useful for patients who experience migraine recurrence within 24 hours.
- Menstrual Migraine: Often used off-label for the short-term prophylaxis of menstrual-related migraines.
Dosage & Administration
Naratriptan should be taken as soon as possible after the onset of a migraine headache, though it is effective regardless of when it is taken during an attack.
- Adults (18-65 years): The standard dose is 2.5 mg taken orally with water.
- Repeat Dosing: If the headache returns or if the patient only partially responds, a second dose may be taken after 4 hours.
- Maximum Dose: Do not exceed 5 mg (two 2.5 mg tablets) in any 24-hour period.
- Renal/Hepatic Impairment: For patients with mild to moderate impairment, the maximum daily dose is 2.5 mg. It is contraindicated in severe impairment.
Description & Pharmacokinetics
Naratriptan is a second-generation triptan. It works by binding selectively to 5-HT1B and 5-HT1D receptors.
This binding leads to the constriction of cranial blood vessels and inhibits the release of pro-inflammatory neuropeptides (like CGRP) from trigeminal nerve endings.
Pharmacokinetics: Naratriptan is well-absorbed with a bioavailability of 70%. Its peak plasma concentration is reached in 2–3 hours. Unlike other triptans, it has a long elimination half-life of approximately 6 hours, which accounts for its lower rate of headache recurrence. It is primarily cleared by the kidneys (50% unchanged) and the liver.
Pharmacokinetics: Naratriptan is well-absorbed with a bioavailability of 70%. Its peak plasma concentration is reached in 2–3 hours. Unlike other triptans, it has a long elimination half-life of approximately 6 hours, which accounts for its lower rate of headache recurrence. It is primarily cleared by the kidneys (50% unchanged) and the liver.
Extra Important Information: Usage Insights
- Not for Prevention: Naratriptan is strictly for treating an existing headache; it does not reduce the frequency of future attacks if taken daily.
- Slow Onset: Compared to Sumatriptan, Naratriptan acts more slowly but its effects last significantly longer.
- Medication Overuse Headache: Using triptans more than 10 days per month can lead to "rebound" headaches.
Side Effects
Naratriptan is generally well-tolerated. Common side effects include:
- Sensory: Paresthesia (tingling), sensations of warmth or cold.
- Gastrointestinal: Nausea, vomiting, and dry mouth.
- CNS: Dizziness, drowsiness, and malaise/fatigue.
- Chest Symptoms: Rare sensations of heaviness, tightness, or pressure in the chest or throat.
Pregnancy & Lactation
- Pregnancy: Category C. Use only if the potential benefit justifies the risk to the fetus. There is limited data on its use in pregnant women.
- Lactation: Naratriptan is excreted in the milk of lactating rats. Caution should be exercised; it is recommended to avoid breastfeeding for 24 hours after taking a dose.
Precautions & Interactions
- Cardiovascular: Contraindicated in patients with ischemic heart disease (angina, history of MI), uncontrolled hypertension, or peripheral vascular disease.
- Serotonin Syndrome: Risk increases if taken with SSRIs or SNRIs.
- Ergotamines: Avoid use within 24 hours of ergot-type medications as they may cause prolonged vasospasm.
- MAOIs: Unlike other triptans, Naratriptan is NOT significantly metabolized by Monoamine Oxidase; however, general caution is still advised.
Storage
Store at room temperature (20°C to 25°C). Protect from light and moisture. Keep the blister pack intact until use.
.png)
